(S1 (S (S (PP (IN In) (NP (NN conclusion))) (, ,) (NP (PRP$ our) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (NP (NN BMP-6)) (VP (VBZ induces) (NP (NP (NN activation)) (PP (IN of) (NP (JJ intracellular) (NN Smad) (NN signalling))) (PP (IN in) (NP (JJ mature) (JJ human) (NNS B-cells)))) (PP (IN with) (NP (NP (JJ consecutive) (NN production)) (PP (IN of) (NP (NN Id1) (NN protein)))))))))) (. .)))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (PRP we)) (VP (VBP report) (SBAR (IN that) (S (NP (NN BMP-6)) (VP (VBZ has) (NP (DT an) (JJ antiproliferative) (NN effect)) (PP (IN in) (NP (NP (NN B) (NNS cells)) (VP (VBN stimulated) (PP (IN with) (NP (NP (NP (NN anti-IgM)) (ADVP (RB alone))) (CC or) (NP (NP (DT the) (JJ combined) (NN action)) (PP (IN of) (NP (NP (NN anti-IgM)) (CC and) (NP (NN CD40L))))))))))))))) (. .)))
(S1 (S (S (ADVP (RB Additionally)) (, ,) (NP (NN BMP-6)) (VP (VBZ induces) (NP (NN cell) (NN death)) (PP (IN in) (NP (NP (VBN activated) (NN memory) (NN B) (NNS cells)) (CC and) (NP (NN Ramos) (NNS cells)))))) (. .)))
(S1 (S (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (NP (DT these) (NNS results)) (VP (VBP provide) (NP (NP (DT a) (NN rationale)) (S (VP (TO to) (ADVP (RB further)) (VP (VB examine) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN BMP-6) (NN signalling))) (PP (PP (IN in) (NP (JJ normal) (NN B) (NN cell) (NN biology))) (CONJP (RB as) (RB well) (IN as)) (PP (IN in) (NP (NP (NP (JJ pathologic) (NNS conditions)) (PP (IN like) (NP (NN B) (NN cell) (NNS malignancies)))) (CC and) (NP (JJ autoimmune) (NNS disorders)))))))))))) (. .)))
